NCT03861897 (KINEPANCH) is a NA clinical trial of KRP-NI + KM in Infectious Pleural Effusion, sponsored by Hôpital NOVO.

Who is sponsoring NCT03861897?

NCT03861897 is sponsored by Hôpital NOVO.

What drugs are being tested in NCT03861897?

Interventions in NCT03861897: KRP-NI + KM, KM.

What condition does NCT03861897 study?

NCT03861897 studies Infectious Pleural Effusion.

Is NCT03861897 still recruiting?

NCT03861897 is currently completed. Last updated 31 December 2024.

Last reviewed 2024-12-31 · How we verify

NCT03861897: KINEPANCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Non-instrumental Pleural Chest Physiotherapy

Completed NA Last updated 31 December 2024

What this trial tests

NA trial testing KRP-NI + KM in Infectious Pleural Effusion in 82 participants. Completed in 11 December 2024.

Timeline

6 June 2019

Primary endpoint
23 September 2024

11 December 2024

Quick facts

Lead sponsor	Hôpital NOVO
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	82
Start date	6 June 2019
Primary completion	23 September 2024
Estimated completion	11 December 2024
Sites	11 locations across France

Drugs / interventions tested

KRP-NI + KM
KM

Conditions studied

Infectious Pleural Effusion — all drugs for Infectious Pleural Effusion →

Sponsor

Hôpital NOVO — full company profile →

Who can join

18 and older, any sex, with Infectious Pleural Effusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this study is to assess efficacy of non instrumental pleural chest physiotherapy on the recovery of respiratory function, at hospital discharge or 15 days after beginning the pleural chest physiotherapy, compared to physiotherapy with standard mobilization, in patients with infectious pleural effusion, who have received usual medical treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hôpital NOVO trials

Trials by the same sponsor.

NCT07394478 — Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica · not yet recruiting
NCT07412340 — Disarticulation Septoplasty Versus Classical Way · not yet recruiting
NCT07298070 — Functional and Aesthetic Outcomes Following Lower Lip Reconstruction · not yet recruiting
NCT07257094 — Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Reha · recruiting
NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03861897 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hôpital NOVO
Last refreshed: 31 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03861897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing